ShareValue scores for SBS.XETRA: Valuation 61, Quality 25, Growth 24, Health 56.

Stratec SE logo

SBS.XETRA
XETRA

Stratec SE

€20.00(-1.23%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

4% to 17%
Valuation
61
Fair Value
Price vs Value
Quality
25
Weak
Business Strength
Growth
24
Weak
Revenue & Earnings
Health
56
Moderate
Financial Stability
Momentum
55
Neutral
Price Trend

Company Details

About

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026